BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12642898)

  • 1. Involvement of tumor necrosis factor receptor superfamily(TNFRSF) members in the pathogenesis of inflammatory diseases.
    Kwon B; Kim BS; Cho HR; Park JE; Kwon BS
    Exp Mol Med; 2003 Feb; 35(1):8-16. PubMed ID: 12642898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily.
    Nocentini G; Riccardi C
    Eur J Immunol; 2005 Apr; 35(4):1016-22. PubMed ID: 15770698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphotoxin and LIGHT signaling pathways and target genes.
    Schneider K; Potter KG; Ware CF
    Immunol Rev; 2004 Dec; 202():49-66. PubMed ID: 15546385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What does tumour necrosis factor excess do to the immune system long term?
    Clark J; Vagenas P; Panesar M; Cope AP
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv70-6. PubMed ID: 16239393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity.
    So T; Lee SW; Croft M
    Int J Hematol; 2006 Jan; 83(1):1-11. PubMed ID: 16443545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uncertain glory of APRIL.
    Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M
    Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway.
    Haga T; Suzuki J; Kosuge H; Ogawa M; Saiki H; Haraguchi G; Maejima Y; Isobe M; Uede T
    J Mol Cell Cardiol; 2009 May; 46(5):719-27. PubMed ID: 19233196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.
    Kamimura Y; Iwai H; Piao J; Hashiguchi M; Azuma M
    J Immunol; 2009 Mar; 182(5):2708-16. PubMed ID: 19234165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TNF-TNFR Family of Co-signal Molecules.
    So T; Ishii N
    Adv Exp Med Biol; 2019; 1189():53-84. PubMed ID: 31758531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
    Cheuk AT; Mufti GJ; Guinn BA
    Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
    Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways.
    Mountz JD; Zhou T; Su X; Cheng J; Pierson M; Bluethmann H; Edwards CK
    Behring Inst Mitt; 1996 Oct; (97):200-19. PubMed ID: 8950477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GITR: a modulator of immune response and inflammation.
    Nocentini G; Riccardi C
    Adv Exp Med Biol; 2009; 647():156-73. PubMed ID: 19760073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF ligands and receptors in autoimmunity: an update.
    Mackay F; Kalled SL
    Curr Opin Immunol; 2002 Dec; 14(6):783-90. PubMed ID: 12413530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
    Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD
    Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular mechanisms of TNF function in models of inflammation and autoimmunity.
    Apostolaki M; Armaka M; Victoratos P; Kollias G
    Curr Dir Autoimmun; 2010; 11():1-26. PubMed ID: 20173385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
    Lin WW; Hsieh SL
    Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GITR/GITRL: more than an effector T cell co-stimulatory system.
    Nocentini G; Ronchetti S; Cuzzocrea S; Riccardi C
    Eur J Immunol; 2007 May; 37(5):1165-9. PubMed ID: 17407102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costimulation of CD28- T lymphocytes by 4-1BB ligand.
    DeBenedette MA; Shahinian A; Mak TW; Watts TH
    J Immunol; 1997 Jan; 158(2):551-9. PubMed ID: 8992967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.
    Gross JA; Johnston J; Mudri S; Enselman R; Dillon SR; Madden K; Xu W; Parrish-Novak J; Foster D; Lofton-Day C; Moore M; Littau A; Grossman A; Haugen H; Foley K; Blumberg H; Harrison K; Kindsvogel W; Clegg CH
    Nature; 2000 Apr; 404(6781):995-9. PubMed ID: 10801128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.